- Q1 2024 Sarepta Therapeutics Inc Earnings Call TranscriptMay 01, 2024$130.9 (+3.35%)Earnings
- Q4 2023 Sarepta Therapeutics Inc Earnings Call TranscriptFeb 28, 2024$137.5 (-2.85%)Earnings
- Sarepta Therapeutics Inc To Provide Program Update TranscriptJan 29, 2024
- Sarepta Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Sarepta Therapeutics Inc at UBS BioPharma Conference TranscriptNov 09, 2023
- Q3 2023 Sarepta Therapeutics Inc Earnings Call TranscriptNov 01, 2023$76.52 (+13.68%)Earnings
- Sarepta Therapeutics Inc Update Call TranscriptOct 30, 2023
- Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Sarepta Therapeutics Inc Earnings Call TranscriptAug 02, 2023$105.19 (-2.18%)Earnings
- Sarepta Therapeutics Inc at TD Cowen RNA Therapeutics Summit (Virtual) TranscriptJul 10, 2023
- Sarepta Therapeutics Inc ELEVIDYS FDA Accelerated Approval Call TranscriptJun 22, 2023
- Q1 2023 Sarepta Therapeutics Inc Earnings Call TranscriptMay 02, 2023$123.69 (-1.14%)Earnings
- Sarepta Therapeutics Inc SRP-9001 BLA Update Call TranscriptMar 16, 2023
- Q4 2022 Sarepta Therapeutics Inc Earnings Call TranscriptFeb 28, 2023$122.13 (+3.39%)Earnings
- Sarepta Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Sarepta Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Q3 2022 Sarepta Therapeutics Inc Earnings Call TranscriptNov 02, 2022$113.42 (-0.58%)Earnings
- Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Sarepta Therapeutics Inc Earnings Call TranscriptAug 02, 2022$94.01 (+2.69%)Earnings
- Sarepta Therapeutics Inc to Discuss New Clinical Data and Integrated Analysis Call TranscriptJul 06, 2022
- Sarepta Therapeutics Inc to Provides Update on SRP-5051 for the Treatment of Duchenne TranscriptJun 23, 2022
- Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Sarepta Therapeutics Inc Annual Shareholders Meeting TranscriptJun 02, 2022
- Sarepta Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Sarepta Therapeutics Inc Earnings Call TranscriptMay 04, 2022$72.75 (-0.79%)Earnings
- Sarepta Therapeutics Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) TranscriptMar 31, 2022
- Sarepta Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2022
- Sarepta Therapeutics Inc at Cowen Health Care Conference (Virtual) TranscriptMar 09, 2022
- Q4 2021 Sarepta Therapeutics Inc Earnings Call TranscriptMar 01, 2022$76.02 (-0.77%)Earnings
- Sarepta Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) and Q&A Session TranscriptJan 10, 2022
- Sarepta Therapeutics Inc at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Sarepta Therapeutics Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2021
- Q3 2021 Sarepta Therapeutics Inc Earnings Call TranscriptNov 03, 2021$86.53 (+6.13%)Earnings
- Sarepta Therapeutics Inc to host SRP-9001 Micro-dystrophin R&D Day TranscriptOct 11, 2021
- Sarepta Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Sarepta Therapeutics Inc Earnings Call TranscriptAug 04, 2021$67.5 (-2.23%)Earnings
- Sarepta Therapeutics Inc at Bank of America NAPA Healthcare Conference TranscriptJun 16, 2021
- Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Sarepta Therapeutics Inc Annual Shareholders Meeting TranscriptJun 03, 2021
- Sarepta Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- Sarepta Therapeutics Inc Clinical Update: Study SRP-9001-103: 12-Week Expression and Safety Data Using Commercially Representative Material - Call TranscriptMay 18, 2021
- Sarepta Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Sarepta Therapeutics Inc Earnings Call TranscriptMay 05, 2021$72.77 (-1.69%)Earnings
- Sarepta Therapeutics Inc to Discuss Results from 30 mg/kg Cohort of MOMENTUM Study of SRP-5051 for Duchenne Muscular Dystrophy Call TranscriptMay 03, 2021
- Pfizer Inc, Avidity Biosciences, Sarepta Therapeutics, Solid Biosciences, and Ultragenyx Pharmaceutical at Guggenheim Partners Healthcare Talks: Genomic Medicines & Rare Disease (Virtual) TranscriptApr 01, 2021
- Sarepta Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Sarepta Therapeutics Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Sarepta Therapeutics Inc Earnings Call TranscriptMar 01, 2021$87.03 (-0.03%)Earnings
- Sarepta Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Sarepta Therapeutics Inc Announces Top-line Results from Part 1 of Study SRP-9001-102 Conference Call TranscriptJan 07, 2021
- Sarepta Therapeutics Inc to Present Clinical Update for SRP-5051 Conference Call TranscriptDec 07, 2020
- Sarepta Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 02, 2020
- Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Sarepta Therapeutics Inc Earnings Call TranscriptNov 05, 2020$145.15 (-4.44%)Earnings
- Sarepta Therapeutics Inc Conference Call to Discuss Long-term Functional Data from Gene Therapy Programs to be Presented at WMS25 TranscriptSep 28, 2020
- Sarepta Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Sarepta Therapeutics Inc at Robert W Baird Global Healthcare Conference TranscriptSep 10, 2020
- Q2 2020 Sarepta Therapeutics Inc Earnings Call TranscriptAug 05, 2020$158.89 (+1.38%)Earnings
- Sarepta Therapeutics Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) TranscriptJun 24, 2020
- Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call TranscriptJun 08, 2020
- Sarepta Therapeutics Inc Annual Shareholders Meeting TranscriptJun 04, 2020
- Sarepta Therapeutics Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Q1 2020 Sarepta Therapeutics Inc Earnings Call TranscriptMay 06, 2020$122.57 (+2.62%)Earnings
- Q4 2019 Sarepta Therapeutics Inc Earnings Call TranscriptFeb 26, 2020$113.63 (-0.14%)Earnings
- Sarepta Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Sarepta Therapeutics Inc to Discuss Partnership with Roche Holding AG for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy Call TranscriptDec 23, 2019
- Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Sarepta Therapeutics Inc Earnings Call TranscriptNov 07, 2019$93.38 (+1.16%)Earnings
- Sarepta Therapeutics Inc Limb-Girdle Muscular Dystrophy Type 2E Conference Call TranscriptOct 04, 2019
- Sarepta Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Sarepta Therapeutics Inc Earnings Call TranscriptAug 07, 2019$142.26 (-0.87%)Earnings
- Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Q1 2019 Sarepta Therapeutics Inc Earnings Call TranscriptMay 08, 2019$114.5 (-1.46%)Earnings
- Sarepta Therapeutics Inc Update on Duchenne Muscular Dystrophy Gene Therapy Program Conference Call TranscriptMar 25, 2019
- Q4 2018 Sarepta Therapeutics Inc Earnings Call TranscriptFeb 27, 2019$151.68 (+8.31%)Earnings
- Sarepta Therapeutics Inc to Announce Results of Phase I/IIa Gene Transfer Clinical Trial using MYO-101 - Conference Call TranscriptFeb 27, 2019
Q1 2024 Sarepta Therapeutics Inc Earnings Call Transcript
Good afternoon, and welcome to the Sarepta Therapeutics First Quarter 2024 Earnings Call. (Operator Instructions) As a reminder, today's program is being recorded.
At this time, I'll turn the call over to Mary Jenkins, Associate Director, Investor Relations and Corporate Communications. Please go ahead.
Thank you, Victor, and thank you all for joining today's call. Earlier this afternoon, we released our financial results for the first quarter of 2024. The press release is available on our website at sarepta.com, and our 10-Q was filed with the Securities and Exchange Commission this afternoon.
Joining us on the call today are Doug Ingram, Ian Estepan, Dallan Murray and Dr. Louise Rodino-Klapac. I'd like to note that during this call, we will be making a number of forward-looking statements. Please take a moment to review our slide on the webcast, which contains our forward-looking statements. These forward-looking statements involve risks and uncertainties, many of which are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)